Psoriasis Flashcards

1
Q

definition

A

chronic skin condition characterised by scaly erythematous plaques, typically relapsing and remitting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pathogenesis

A

the epidermis in the plaques is hyperproliferative
proliferation and dilatation of blood vessels in the epidermis + infiltration of inflammatory cells (T cells +/- neutrophils)
plaque psoriasis the most common form (~90%)
if both parents affected, risk to offspring is ~50%
NB 60% of patients will also be depressed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

triggers

A

stress
infections
skin trauma (Koebner phenomenon), drugs, alcohol, obesity, smoking, climate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Koebner phenomenon

A

the development of psoriasis in an area of skin following trauma, where psoriasis had not been seen previously (Koebnerisation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

chronic plaque psoriasis

A

symmetrical well defined red plaques with silvery scales

extensor surfaces of knees, elbows, scalp and sacrum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

flexural psoriasis

A

plaques in moist flexural areas (axilla, groins, submammary and umbilicus)
often less scaly and misdiagnosed as fungal infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

guttate psoriasis

A

large numbers of small plaques (<1cm) over the trunk and limbs are seen in the young
especially after strep infections
usually lasting 3-4 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

pustular psoriasis

A

yellow/brown pustules with plaques affecting the palms and soles (M:F, 9:1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

generalised (erythrodermic) psoriasis

and generalised pustular psoriasis

A

may cause severe systemic upset (fever, increased WCC, dehydration)
medical emergencies requiring urgent hospital referral
NB also triggered by rapid withdrawal of steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

nail changes

A

in 50% of cases
pitting
onycholysis (separation from the nail bed)
thickening and subungual hyperkeratosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

psoriatic arthropathy

A

7% develop seronegative arthropathy (no rheumatoid factor)
5 types:
1. monoarthritis or oligomonoarthritis
2. psoriatic spondylitis
3. asymmetrical polyarthritis
4. arthritis multilans (destructive) (can lead to telescoping when occurring in fingers
5. rheumatoid-like polyarthritis

Rx: NSAIDs, DMARDs (eg methotrexate) and anti-TNF agents (eg infliximab ?)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

management

A

education is vital
control not cure
find out what the patient finds the most distressing
consider phototherapy or systemic therapy if >10% of body surface affected
emollients reduce scale and help relieve irritation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

topical Tx

A

plaque psoriasis: use a topical corticosteroid (eg betnovate) once a day, + a topical vit D preparation (eg dovonex) which affects cell division, once a day
do not use potent corticosteroids for more than 8 weeks, and have a treatment break of 4 weeks before restarting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

phototherapy

A

most useful in uncontrolled guttate or plaque psoriasis or when the disease is widespread (+/- topical adjunctive or systemic treatment)

PUVA (psoralen + UVA) is suitable for extensive large plaque psoriasis (oral psoralen) or pustular psoriasis (topical psoralen)
there is increased risk of skin Ca, especially SCC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

non-biologic oral drugs

A

for severe psoriasis
methotrexate 10-20mg/week PO
most useful in elderly patients, or psoriatic arthropathy
avoid in young due to long term risk of hepatic fibrosis
monitor FBC and LFT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

biological drugs

A

inhibit T-cell activation and function, or neutralise cytokines
consider infliximab, adalimumab, etanercept (TNF antagonists) or if these have failed, ustekinumab (interleukin inhibitor)
all are for specialist use only